Advertisement Banner
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
HealthNews
No Result
View All Result
Home Medicine

Lunit to deliver AI imaging solutions to Bumrungrad International Hospital

admin by admin
July 5, 2022
in Medicine



Lunit has partnered with Fujifilm Thailand and Microsoft to bring its AI radiology solutions to Bumrungrad International Hospital, a private hospital based in Bangkok.

According to a press statement, Lunit is deploying its chest x-ray analysis software INSIGHT CXR and mammography tool INSIGHT MMG in the hospital. 

Together with Fujifilm Thailand, Lunit will supply its AI solutions to Bumrungrad using Microsoft Azure, which the company claims will enhance the operation of its software.

WHY IT MATTERS

Bumrungrad is one of the largest private hospitals in Southeast Asia with 580 beds, serving over a million patients each year across 190 countries.

The hospital aims to provide better services through its timely detection of chest abnormalities and breast cancer using AI.

“AI would be a support tool for human decision-making, providing a second opinion for doctors’ consideration during the diagnostic process,” said Dr Teeradache Viangteeravat, Bumrungrad’s R&D director.

Presently, the hospital is using the Lunit AI solutions in its check-ups, intensive care units, and emergency rooms. The INSIGHT CXR and INSIGHT MMG have so far analysed more than 100,000 images taken each year in the hospital. 

Bumrungrad also expects that the AI solutions will help “speed up the learning curve for junior doctors with less experience in reading images”.

Lunit said it plans to support Bumrungrad further to “drive groundbreaking medical innovation across Southeast Asia”.

THE LARGER TREND

Early this year, a similar deployment deal was signed between Lunit and Egypt-based Baheya Foundation. The non-profit charity group, which provides free-of-charge care for breast cancer patients, has adopted the Lunit INSIGHT MMG.

In other news, Lunit recently got its chest x-ray and mammography solutions cleared for market release in Canada. This followed the approval of the US Food and Drug Administration for the same AI products last year.

Last month, Lunit filed a registration statement with the Korean Exchange for an initial public offering this July. The company plans to issue a total of 1.12 million shares worth between $34-$38 apiece.



Source link

Advertisement Banner
Previous Post

Sentient AI? Convincing you it’s human is just part of LaMDA’s job

Next Post

Headache Updates: Breakthrough Combo, High-Fat Meals, Visual Snow

Next Post

Headache Updates: Breakthrough Combo, High-Fat Meals, Visual Snow

Discussion about this post

Recommended

Pneumococcal 15-Valent Conjugate Vaccine Approved for Pediatric Use

2 months ago

Ria Health scores $18M for virtual alcohol use disorder treatment

1 month ago

Don't Miss

Celebrating Health for 25 Years

August 8, 2022

Cherry Tomato Salad | Mark’s Daily Apple

August 8, 2022

Digital gastrointestinal care startup Salvo Health launches with $10.5M

August 8, 2022

Natural Language Processing and Digital Health Transformation, Health News, ET HealthWorld

August 8, 2022

© 2022 Pharma News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.

Navigate Site

  • News
  • Medicine
  • Health Tech
  • Health Tech
  • Health Living
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.